Clinical Trial

A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

Completed
View on ClinicalTrials.gov →
Summary
The FOCUS study aims to evaluate the clinical efficacy of 0.1% cyclosporine eye drops solution (Vevizye®, Laboratoires THEA) in patients with moderate to severe dry eye disease characterized by ocular surface inflammation.
Protocol Amendment History 1 change
critical Trial completed 2026-06-23
Trial Details
NCT Number NCT07234318
Lead Sponsor Laboratoires Thea
Conditions Dry Eye Disease (DED)
Enrollment 25 participants
Start Date 2026-01-20
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-14